AAAAAA

   
Results: 1-16 |
Results: 16
SAFETY OF IPSAPIRONE TREATMENT COMPARED WITH LORAZEPAM - DISCONTINUATION EFFECTS
Authors: BUSTO UE NARANJO CA BREMNER KE PEACHEY JE BOLOGA M
Citation: Ue. Busto et al., SAFETY OF IPSAPIRONE TREATMENT COMPARED WITH LORAZEPAM - DISCONTINUATION EFFECTS, Journal of psychiatry & neuroscience, 23(1), 1998, pp. 35-44
ECONOMIC-EVALUATION OF RISPERIDONE (R) IN THE TREATMENT OF SCHIZOPHRENIA (SCZ)
Authors: OH P SONI J RISEBROUGH N BREMNER KE LANCTOT KL NARANJO CA
Citation: P. Oh et al., ECONOMIC-EVALUATION OF RISPERIDONE (R) IN THE TREATMENT OF SCHIZOPHRENIA (SCZ), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 93-93
GENDER VARIATIONS IN RESPONSE TO CITALOPRAM (C) AND A BRIEF PSYCHOSOCIAL INTERVENTION (BPI) FOR ALCOHOL DEPENDENCE (AD)
Authors: NARANJO CA BREMNER KE
Citation: Ca. Naranjo et Ke. Bremner, GENDER VARIATIONS IN RESPONSE TO CITALOPRAM (C) AND A BRIEF PSYCHOSOCIAL INTERVENTION (BPI) FOR ALCOHOL DEPENDENCE (AD), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 131-131
PHARMACOTHERAPY OF LATE-LIFE MOOD DISORDERS
Authors: HERRMANN N BREMNER KE NARANJO CA
Citation: N. Herrmann et al., PHARMACOTHERAPY OF LATE-LIFE MOOD DISORDERS, Clinical neuroscience, 4(1), 1997, pp. 41-47
LONG-ACTING INJECTABLE BROMOCRIPTINE DOES NOT REDUCE RELAPSE IN ALCOHOLICS
Authors: NARANJO CA DONGIER M BREMNER KE
Citation: Ca. Naranjo et al., LONG-ACTING INJECTABLE BROMOCRIPTINE DOES NOT REDUCE RELAPSE IN ALCOHOLICS, Addiction, 92(8), 1997, pp. 969-978
SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND CNS DRUG-INTERACTIONS - ACRITICAL-REVIEW OF THE EVIDENCE
Authors: SPROULE BA NARANJO CA BREMNER KE HASSAN PC
Citation: Ba. Sproule et al., SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND CNS DRUG-INTERACTIONS - ACRITICAL-REVIEW OF THE EVIDENCE, Clinical pharmacokinetics, 33(6), 1997, pp. 454-471
USING FUZZY-LOGIC TO PREDICT RESPONSE TO CITALOPRAM IN ALCOHOL DEPENDENCE
Authors: NARANJO CA BREMNER KE BAZOON M TURKSEN IB
Citation: Ca. Naranjo et al., USING FUZZY-LOGIC TO PREDICT RESPONSE TO CITALOPRAM IN ALCOHOL DEPENDENCE, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 209-224
RESEARCH STRATEGIES TO ASSESS PHARMACOTHERAPIES FOR ALCOHOLISM
Authors: NARANJO CA BREMNER KE POULOS CX
Citation: Ca. Naranjo et al., RESEARCH STRATEGIES TO ASSESS PHARMACOTHERAPIES FOR ALCOHOLISM, Progress in neuro-psychopharmacology & biological psychiatry, 20(4), 1996, pp. 543-559
ABUSE OF PRESCRIPTION AND LICIT PSYCHOACTIVE SUBSTANCES BY THE ELDERLY - ISSUES AND RECOMMENDATIONS
Authors: NARANJO CA HERRMANN N OZDEMIR V BREMNER KE
Citation: Ca. Naranjo et al., ABUSE OF PRESCRIPTION AND LICIT PSYCHOACTIVE SUBSTANCES BY THE ELDERLY - ISSUES AND RECOMMENDATIONS, CNS DRUGS, 4(3), 1995, pp. 207-221
RECENT ADVANCES IN GERIATRIC PSYCHOPHARMACOLOGY
Authors: NARANJO CA HERRMANN N MITTMANN N BREMNER KE
Citation: Ca. Naranjo et al., RECENT ADVANCES IN GERIATRIC PSYCHOPHARMACOLOGY, Drugs & aging, 7(3), 1995, pp. 184-202
RITANSERIN, A CENTRAL 5-HT2 ANTAGONIST, IN HEAVY SOCIAL DRINKERS - DESIRE TO DRINK, ALCOHOL INTAKE AND RELATED EFFECTS
Authors: NARANJO CA POULOS CX LANCTOT KL BREMNER KE KWOK M UMANA M
Citation: Ca. Naranjo et al., RITANSERIN, A CENTRAL 5-HT2 ANTAGONIST, IN HEAVY SOCIAL DRINKERS - DESIRE TO DRINK, ALCOHOL INTAKE AND RELATED EFFECTS, Addiction, 90(7), 1995, pp. 893-905
EFFECTS OF CITALOPRAM AND BRIEF PSYCHOSOCIAL INTERVENTION ON ALCOHOL INTAKE, DEPENDENCE AND PROBLEMS
Authors: NARANJO CA BREMNER KE LANCTOT KL
Citation: Ca. Naranjo et al., EFFECTS OF CITALOPRAM AND BRIEF PSYCHOSOCIAL INTERVENTION ON ALCOHOL INTAKE, DEPENDENCE AND PROBLEMS, Addiction, 90(1), 1995, pp. 87-99
LONG-ACTING BROMOCRIPTINE (B) DOES NOT REDUCE RELAPSE IN ALCOHOLICS
Authors: NARANJO CA BREMNER KE VACHON L BLAKE J
Citation: Ca. Naranjo et al., LONG-ACTING BROMOCRIPTINE (B) DOES NOT REDUCE RELAPSE IN ALCOHOLICS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 161-161
DIAGNOSIS AND PHARMACOLOGICAL TREATMENT OF ALCOHOLIC PATIENTS
Authors: NARANJO CA OZDEMIR V BREMNER KE
Citation: Ca. Naranjo et al., DIAGNOSIS AND PHARMACOLOGICAL TREATMENT OF ALCOHOLIC PATIENTS, CNS DRUGS, 1(5), 1994, pp. 330-340
TREATMENT OF ALCOHOL-WITHDRAWAL SYNDROME
Authors: OZDEMIR V BREMNER KE NARANJO CA
Citation: V. Ozdemir et al., TREATMENT OF ALCOHOL-WITHDRAWAL SYNDROME, Annals of medicine, 26(2), 1994, pp. 101-105
FLUOXETINE ATTENUATES ALCOHOL INTAKE AND DESIRE TO DRINK
Authors: NARANJO CA POULOS CX BREMNER KE LANCTOT KL
Citation: Ca. Naranjo et al., FLUOXETINE ATTENUATES ALCOHOL INTAKE AND DESIRE TO DRINK, International clinical psychopharmacology, 9(3), 1994, pp. 163-172
Risultati: 1-16 |